Abstract
Gait disorders have been identified as one of the most influential physical impairments associated with deterioration in daily living activities among the elderly. A better understanding of the mechanisms responsible for gait disorders is important for developing intervention strategies for the elderly. In recent years, positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG) have been used to monitor glucose uptake by skeletal muscle during exercise. This review discusses recent studies in which FDG PET has been used to measure muscular glucose uptake, differences between young adults and the elderly in muscular glucose uptake during walking, and the usefulness of FDG PET for determining the effects of exercise intervention in the elderly.
Keywords: FDG, positron emission tomography, physical activity, exercise, aged, skeletal muscle, gait disorder
Current Aging Science
Title: Imaging of Glucose Uptake During Walking in Elderly Adults
Volume: 5 Issue: 1
Author(s): Hiroyuki Shimada
Affiliation:
Keywords: FDG, positron emission tomography, physical activity, exercise, aged, skeletal muscle, gait disorder
Abstract: Gait disorders have been identified as one of the most influential physical impairments associated with deterioration in daily living activities among the elderly. A better understanding of the mechanisms responsible for gait disorders is important for developing intervention strategies for the elderly. In recent years, positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG) have been used to monitor glucose uptake by skeletal muscle during exercise. This review discusses recent studies in which FDG PET has been used to measure muscular glucose uptake, differences between young adults and the elderly in muscular glucose uptake during walking, and the usefulness of FDG PET for determining the effects of exercise intervention in the elderly.
Export Options
About this article
Cite this article as:
Shimada Hiroyuki, Imaging of Glucose Uptake During Walking in Elderly Adults, Current Aging Science 2012; 5(1) . https://dx.doi.org/10.2174/1874609811205010051
DOI https://dx.doi.org/10.2174/1874609811205010051 |
Print ISSN 1874-6098 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-6128 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Genetic Features of MAPT, GRN, C9orf72 and CHCHD10 Gene Mutations in Chinese Patients with Frontotemporal Dementia
Current Alzheimer Research Neuroprotection by Association of Palmitoylethanolamide with Luteolin in Experimental Alzheimer’s Disease Models: The Control of Neuroinflammation
CNS & Neurological Disorders - Drug Targets Cholinesterases and Cholinesterase Inhibitors
Current Enzyme Inhibition Structural Analysis of Relevant Drug Targets for Alzheimer's Disease: Novel Approaches to Drug Development
Current Bioactive Compounds Re-Balancing of Inflammation and Aβ Immunity as a Therapeutic for Alzheimers Disease-View from the Bedside
CNS & Neurological Disorders - Drug Targets Green Synthesis of Phosphoryl-2-Oxo-2H-Pyran via Three Component Reaction of Trialkyl Phosphites
Combinatorial Chemistry & High Throughput Screening The Impact of Mitochondrial DNA and Nuclear Genes Related to Mitochondrial Functioning on the Risk of Parkinson’s Disease
Current Genomics Synthesis and Cholinesterase Inhibition Activity of New Pyrrolopyrimidine Derivatives
Letters in Drug Design & Discovery Differential Cued-Stroop Performance in Cognitively Asymptomatic Older Adults with Biomarker-Identified Risk for Alzheimer’s Disease: A Pilot Study
Current Alzheimer Research Accurate and Unbiased Quantitation of Amyloid-β Fluorescence Images Using ImageSURF
Current Alzheimer Research Pyruvate Dehydrogenase Kinases in the Nervous System: Their Principal Functions in Neuronal-glial Metabolic Interaction and Neuro-metabolic Disorders
Current Neuropharmacology New Insights on the Beneficial Effects of the Probiotic Kefir on Vascular Dysfunction in Cardiovascular and Neurodegenerative Diseases
Current Pharmaceutical Design Preclinical Safety and Pharmacokinetic Profile of 3K3A-APC, a Novel, Modified Activated Protein C for Ischemic Stroke
Current Pharmaceutical Design High PIB Retention in Alzheimers Disease is an Early Event with Complex Relationship with CSF Biomarkers and Functional Parameters
Current Alzheimer Research Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Plasma Clusterin as a Potential Biomarker for Alzheimer’s Disease-A Systematic Review and Meta-analysis
Current Alzheimer Research Vasculogenic and Angiogenic Pathways in Moyamoya Disease
Current Medicinal Chemistry Cerebral Aneurysm as an Exacerbating Factor in Stroke Pathology and a Therapeutic Target for Neuroprotection
Current Pharmaceutical Design Emerging Evidence for the Role of Neurotransmitters in the Modulation of T Cell Responses to Cognate Ligands
Central Nervous System Agents in Medicinal Chemistry Quinoline Derivatives: Candidate Drugs for a Class B G-Protein Coupled Receptor, the Calcitonin Gene-Related Peptide Receptor, a Cause of Migraines
CNS & Neurological Disorders - Drug Targets